These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8743731)

  • 1. Effects of a highly selective synthetic inhibitor of plasma kallikrein on disseminated intravascular coagulation in rats.
    Katsuura Y; Okamoto S; Ohno N; Wanaka K
    Thromb Res; 1996 May; 82(4):361-8. PubMed ID: 8743731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
    Okamoto S; Wanaka K; Hijikata-Okunomiya A; Okada Y; Katsuura Y
    Agents Actions Suppl; 1992; 38 ( Pt 1)():198-205. PubMed ID: 1466271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysis.
    Wanaka K; Okamoto S; Bohgaki M; Hijikata-Okunomiya A; Naito T; Okada Y
    Thromb Res; 1990 Mar; 57(6):889-95. PubMed ID: 2382257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Uchiba M; Okajima K; Murakami K; Okabe H; Okamoto S; Okada Y
    Thromb Haemost; 1997 Oct; 78(4):1209-14. PubMed ID: 9364986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
    Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a highly selective plasma kallikrein inhibitor on collagen-induced arthritis in mice.
    Fujimori Y; Nakamura T; Shimizu K; Yamamuro T; Wanaka K; Okamoto S; Katsuura Y
    Agents Actions; 1993 May; 39(1-2):42-8. PubMed ID: 8285139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
    Izutani W; Fujita M; Nishizawa K; Koga J
    Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Asakura H; Sano Y; Omote M; Yoshida T; Ontachi Y; Mizutani T; Kaneda M; Yamazaki M; Morishita E; Takami A; Miyamoto K; Nakao S
    Int J Hematol; 2004 May; 79(4):394-9. PubMed ID: 15218973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of activated platelets in endotoxin-induced DIC in rats.
    Ito T; Asai F; Oshima T; Kobayashi S
    Thromb Res; 1990 Aug; 59(4):735-47. PubMed ID: 2080492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of plasma kallikrein inhibitors: functional and structural requirements of plasma kallikrein inhibitors.
    Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
    Chem Pharm Bull (Tokyo); 1998 Mar; 46(3):452-7. PubMed ID: 9549887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    Fujita M; Izutani W; Komurasaki Y
    Thromb Haemost; 2000 Jul; 84(1):54-8. PubMed ID: 10928470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
    Yamazaki M; Aoshima K; Mizutani T; Ontachi Y; Saito M; Morishita E; Asakura H; Matsuda T; Triplett DA
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):321-30. PubMed ID: 10493213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation and fibrinolytic factors and their inhibitors in critically ill patients.
    Hellgren M; Egberg N; Eklund J
    Intensive Care Med; 1984; 10(1):23-8. PubMed ID: 6559831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of ONO-3307, a new synthetic protease inhibitor against experimental disseminated intravascular coagulation in rats.
    Yoshikawa T; Takeda S; Naito Y; Kondo M
    Thromb Res; 1990 Oct; 60(1):1-7. PubMed ID: 2278034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
    Hara T; Yokoyama A; Tanabe K; Ishihara H; Iwamoto M
    Thromb Haemost; 1995 Aug; 74(2):635-9. PubMed ID: 8584999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
    Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
    Taylor FB; Wada H; Kinasewitz G
    Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
    Fukumizu A; Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1141-4. PubMed ID: 10478469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
    Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.